Advertisement
YOU ARE HERE: LAT HomeCollectionsE 5 Drug
IN THE NEWS

E 5 Drug

FEATURED ARTICLES
BUSINESS
September 5, 1991 | From Times Staff and Wire Reports
FDA Panel Seeks More Time for Drug Studies: A panel of experts concluded that a genetically engineered drug designed to treat an often-fatal blood infection is safe, but declined to recommend approval for sale without more research. The panel, made up of outside experts who advise the U.S. Food and Drug Administration, wants more time to study the effectiveness of a drug called Centoxin developed by Centocor Inc., of Malvern, Pa.
ARTICLES BY DATE
BUSINESS
September 5, 1991 | From Times Staff and Wire Reports
FDA Panel Seeks More Time for Drug Studies: A panel of experts concluded that a genetically engineered drug designed to treat an often-fatal blood infection is safe, but declined to recommend approval for sale without more research. The panel, made up of outside experts who advise the U.S. Food and Drug Administration, wants more time to study the effectiveness of a drug called Centoxin developed by Centocor Inc., of Malvern, Pa.
Advertisement
BUSINESS
September 5, 1991 | From Times Wire Services
Wall Street stocks posted declines for the fourth straight session Wednesday, but trading was tentative ahead of a key economic report expected Friday. The Dow Jones average of 30 blue chips, up about 5 points briefly in the early going, closed with a 9.17-point loss at 3,008.50. In the four trading days since it hit a record closing high of 3,055.23 on Aug. 28, the average has fallen 46.73 points. Declining issues outnumbered advances 1,016 to 554 on the New York Stock Exchange.
Los Angeles Times Articles
|